CLINICAL_TRIALS
trial_result
· 2020-01-23
Clinical Trial Update: Bioavailability of Apixaban Sprinkle Compared to Apixaban Capsules [Phase 1]
Summary
Phase 1 study comparing the bioavailability of apixaban sprinkle formulation to standard capsule in healthy volunteers; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Healthy Volunteers | Phase 1 | Status: COMPLETED | Results posted: 2020-01-23